Jeb Ledell

Jeb Ledell is an experienced biotech executive who has held several leadership positions in the pharmaceutical and biotechnology industries. Here are some key details about his career:

Professional Experience

AVEO Oncology: Jeb Ledell currently serves as the Chief Operating Officer at AVEO Oncology, a commercial-stage biopharmaceutical company focused on developing cancer treatments.1 He joined AVEO in December 2021, bringing over 20 years of biotech leadership experience to the role.1

Enzyvant Therapeutics: Prior to joining AVEO, Ledell was the Chief Operating Officer at Enzyvant Therapeutics, a biotechnology company specializing in developing therapies for rare diseases.2 At Enzyvant, he led key business operations during the U.S. Food and Drug Administration approval of RETHYMIC®, a regenerative therapy.13

Previous Roles:

• Chief Operating Officer at Compass Therapeutics
• Chief Operating Officer at Horizon Discovery Group
• Various technology, operations, and development roles at Zalicus Inc.23

Education

Jeb Ledell holds a BS degree in Chemical Engineering from Worcester Polytechnic Institute.13

Skills and Expertise

Ledell is known for his:

• Extensive leadership experience in the biotech industry
• Proven track record across key business functions
• Ability to manage organizational growth and changes in scale12

His LinkedIn profile describes him as an "Experienced Executive with Proven Leadership and Execution Ability".4

Jeb Ledell's career trajectory demonstrates his expertise in operations management and his ability to lead biotechnology companies through critical phases of growth and product development.